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Several recent case reports describe the endovascular man-
agement of AEFs in high-risk patients and suggest lower
perioperative morbidity and mortality rates than tradi-
tional surgery.21-25 This study documents the use of
endovascular techniques as a means of treatment for seven
patients with primary and secondary AEFs in a 5-year
period at a single institution.
PATIENTS AND METHODS
Demographics. In a 5-year period, 467 patients
underwent endovascular repair of an abdominal aortic
aneurysm at the Mount Sinai Medical Center and were
entered prospectively into a vascular registry. All patients
were considered for endografting in accordance with an
investigator-sponsored Investigational Device Exemption
from the US Food and Drug Administration, with the
approval of the Mount Sinai Medical Center Institutional
Review Board. Informed consent was obtained from all
patients. Of these, seven patients were treated for an AEF
(Table I). There were six men and one woman, whose
ages ranged from 48 to 92 years (mean, 76 years). All
patients were considered to be at high-risk for surgical
repair because of significant comorbid disease (Table II).
Two patients had a primary AEF, and five patients had a
secondary AEF. All five patients with a secondary AEF had
their initial operation for an abdominal aortic aneurysm or
thoracoabdominal aneurysm, four electively and one
emergently because of aneurysm rupture. The mean inter-
Aortoenteric fistula (AEF) remains a catastrophic com-
plication with a high morbidity and mortality, despite
numerous strategies for surgical treatment. Primary AEFs
are uncommon and occur when a large, previously untreated
aneurysm erodes into the adjacent bowel. The more com-
mon secondary AEF occurs in 0.3% to 1.6%1-8 of patients
after aortic prosthetic reconstruction. Conventional treat-
ment of an AEF consists of extra-anatomic bypass grafting,
aortic ligation, and, for a secondary AEF, subsequent graft
removal. This technique is associated with a 25% to 90%
operative mortality rate,5-8,9-19 an amputation rate of 5% to
25%,9-15 and an aortic stump rupture rate of 10% to 50%.10
In-situ aortic reconstruction has been proposed as a less-
morbid alternative to ligation and bypass grafting.
However, the average perioperative mortality rate for in-
situ reconstruction is reported to be 27% to 30%.9,10,20
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Purpose: Aortoenteric fistula (AEF) is an uncommon but catastrophic complication that can occur either primarily or
after aortic reconstruction. Untreated, it is uniformly fatal. Conventional surgical management is associated with a peri-
operative mortality rate of 25% to 90% and frequent major complications. We reviewed our experience with the
endovascular treatment of both primary and secondary AEFs in an effort to determine whether endovascular repair is
a less morbid alternative to traditional surgical treatment in select patients.
Methods: In a 5-year period, seven high-risk patients who had bleeding and an AEF documented by means of radiology
or endoscopy (2 primary, 5 secondary) were treated with coil embolization (1) or placement of an endovascular aortic
stent graft (3 aortouniiliac, 2 tube, 1 bifurcated). One patient underwent computed tomography (CT)-guided percu-
taneous catheter drainage of an infected perigraft collection. The average follow-up period was 27 months (range, 11-
66 months), and follow-up consisted of physical examination, complete blood count, and contrast-enhanced helical CT
scanning at 3, 6, and 12 months and yearly thereafter. All patients were treated with intravenous antibiotics perioper-
atively and were prescribed life-long oral antibiotics on discharge.
Results: There was one perioperative death (14%) caused by fungal sepsis. Persistent sepsis after stent-graft placement
necessitated laparotomy and bowel resection in one patient. One patient had three bouts of recurrent sepsis that were
successfully treated with a change of antibiotic. There were three late deaths (43%) unrelated to the procedure or AEF.
Three patients (43%) were alive and well an average of 36 months (range, 23-67 months) after the procedure, with no
clinical or radiologic evidence of recurrent bleeding or infection.
Conclusion: Endovascular management of AEFs is technically feasible and may be the preferred treatment in select
patients with bleeding and no signs of sepsis. In the setting of gross infection, it may also be considered in high-risk
patients as a bridge to more definitive treatment after hemodynamic stabilization and optimization. (J Vasc Surg
2001;34:1055-9.)
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val between initial repair and occurrence of an AEF in
these five patients was 8 years (range, 5-12 years). Five
patients had fistulization to the duodenum or small intes-
tine, one to the thoracic esophagus after thoracoabdomi-
nal aneurysm repair and one to the sigmoid colon.
All patients had active gastrointestinal bleeding; four
of these patients were in frank hemorrhagic shock, defined
as a systolic blood pressure less than 100 mm Hg and a
heart rate of more than 120 beats per minute. Three
patients had clinical evidence of infection, defined as a
temperature of more than 101°F, white blood cell count
of more than 10,000, or perigraft fluid or air found by
means of a computed tomography(CT) scan. All patients
underwent upper and lower endoscopy before interven-
tion. All AEFs were documented either by means of endo-
scopic or radiology (Table III). Endoscopic confirmation
consisted of visualization of the graft and was diagnostic in
three of the seven patients. Radiologic confirmation con-
sisted of either extravasation of contrast on aortic angiog-
raphy, which was seen in two patients, or by the loss of the
fat plane between bowel and aorta on abdominal CT scan
(Fig 1), which was diagnostic in six of the seven patients.
Procedures and devices. The devices used included
Gianturco coils in one patient, custom-made Parodi/
Palmaz aortouniiliac devices in three patients, Talent LPS
(Medtronic, Minneapolis, Minn) tube grafts in two
patients, and the bifurcated Gore Excluder (W.L. Gore,
Flagstaff, Ariz) in one patient. One patient was treated with
thrombogenic coils placed percutaneously (Fig 2). The
remaining six patients were treated with an aortic stent-
graft placed with fluoroscopic guidance via bilateral
femoral artery cutdowns. Device selection was made on the
basis of patient anatomy. One patient underwent CT-
guided percutaneous drainage of the aneurysm sac imme-
diately after stent-graft placement because of the presence
of air and fluid within the sac noted on a preoperative CT
scan (Fig 3). An indwelling catheter was left for 6 weeks
and was irrigated daily with an antibiotic solution. All
patients received life-long suppressive oral antimicrobial
therapy. The antibiotics were selected based on blood cul-
ture and sensitivity data. Recurrent sepsis required a
change of antibiotic agent because of new microbial cul-
ture and sensitivity data. Patients were given intravenous
Fig 1. A, CT scans showing the loss of the fat plane between
bowel and aorta (grey arrow) and the extravasation of contrast at
the distal anastomosis in this same patient (black arrow), 8 years
after tube graft repair of an AAA. B, Diagram (left) illustrating
the angiogram (right) that was performed via a catheter placed
from the right femoral artery. The aortouniiliac stent-graft has
been deployed from the left femoral artery. Before placement of
an excluder in the right common iliac artery, this angiogram,
which shows free extravasation of contrast from the excluded aor-
tic sac to the bowel lumen, was performed.
Fig 2. A, Mesenteric arteriography identifies a large celiac artery
aneurysm in a patient with multiple recurrent episodes of gas-
trointestinal bleeding. B, Selective catheterization of the
aneurysm identifies a communication with the duodenum.
Thrombogenic coils are placed within the aneurysm.
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antibiotics and then changed to life-long oral antibiotics
when signs of sepsis resolved. All patients were prepared
and draped in a sterile manner for possible conversion to
open repair. Anesthesia consisted of locally injected lido-
caine in three patients, epidural anesthesia in three patients,
and general endotracheal anesthesia in one patient. Follow-
up studies included a physical examination, hematocrit
level, white blood cell count, and contrast-enhanced spiral
CT scanning at 3, 6, and 12 months and yearly thereafter.
RESULTS
In a 5-year period, endovascular techniques were used
as a means of treating seven patients with an acutely bleed-
ing AEF (Table I). Follow-up included all seven patients
and ranged from 11 to 67 months (mean, 27 months). All
patients had immediate cessation of bleeding after stent-
graft placement. The three patients who had obvious signs
of graft infection either died or required adjunctive mea-
sures to control persistent sepsis. One patient died in the
perioperative period of overwhelming fungal sepsis.
Persistent sepsis necessitated a proximal diverting ileostomy
on postoperative day 2 in another patient. Signs of sepsis
quickly resolved, and he was discharged home 3 weeks later.
A third patient with a large perigraft collection containing
pockets of air (Fig 3) underwent percutaneous CT-guided
catheter drainage immediately after stent-graft placement.
The catheter was irrigated daily with an antibiotic solution.
Signs of sepsis resolved in 2 weeks, and the patient was dis-
charged home. The percutaneous drain was removed 6
weeks later. Three subsequent bouts of recurrent sepsis
were successfully treated with a change of antibiotic. There
were three late deaths unrelated to the procedure, bleeding,
or graft infection caused by myocardial infarction, stroke,
and pneumonia. Three patients were alive and well at 63,
30, and 19 months postoperatively without clinical evi-
dence of bleeding or graft infection and with normal hema-
tocrit levels and white blood cell counts and no evidence of
aortic pathology found by means of CT scanning. A com-
parison with open repair was not performed. There were no
early or late amputations, embolic events, or graft throm-
boses. There were no recurrent AEFs or aortic ruptures.
DISCUSSION
There is little consensus about the optimal manage-
ment of AEFs. Historically, reported morbidity and mor-
tality rates have been disturbingly high. When patients are
hemodynamically unstable and actively bleeding, results
are even more dismal. Although endovascular manage-
ment of AEFs is clearly not definitive, it does provide rapid
control of bleeding with minimal physiologic insult to the
patient. Most of these patients are elderly and physiologi-
cally compromised, with multiple comorbid conditions
and a limited life expectancy. In our study, three of six
patients (50%) who survived the procedure were dead
within 2 years because of cardiopulmonary disease unre-
lated to their AEF. The other three patients were alive at a
Table I. Presentation, procedures, and outcomes
Interval* Adjunctive Major
Patient Type Location (years) Sepsis Unstable Device§ procedures complications Follow-up
1 1° Celiac aneurysm – – + 4 – – 67 months
to duodenum
2 2° Distal anastomosis 9† + + 1 Diverting Persistent Died at 18 months
to sigmoid colon ileostomy sepsis (CVA)
3 1° AAA to duodenum – – – 1 – – Died at 
13 months (MI)
4 2° Proximal anastomosis 12 – – 3 – – 34 months
to duodenum
5 2° Distal anastomosis 5 – – 1 – – 23 months
to small intestine
6 2° Proximal thoracic 7‡ + + 2 – Persistent sepsis, Died at 26 
anastomosis to esophagus death days (MOSF)
7 2° Proximal anastomosis 8 + + 2 CT-guided Persistent Recurrent sepsis × 3;
to duodenum drainage  of AAA sac sepsis, ATN died at 11 months (MI)
*For 2° AEF, time interval between initial aortic surgery and occurrence of AEF.
†Initial surgery for ruptured AAA.
‡Initial surgery for thoracoabdominal aortic aneurysm
§Device: 1, Aortouniiliac; 2, Talent Dacron tube endograft; 3, Gore Excluder bifurcated endograft; 4, Gianturco coils.
AAA, Abdominal aortic aneurysm; CVA, cerebrovascular accident; MI, myocardial infarction; MOSF, multiple organ system failure; CT, computed tomog-
raphy; ATN, acute tubular necrosis.
Table II. Contraindications to conventional surgical
repair
Patient Age/sex Contraindications
1 48/male Morbid obesity, total gastrectomy, subtotal 
colectomy, ileostomy, granulating open 
abdomen
2 73/male Earlier aortic arch reconstruction and aortic 
valve replacement, CAD
3 82/male CAD, HTN, > 10 cm AAA
4 92/male 99% left main stenosis
5 73/female Unreconstructible 3-vessel CAD
6 76/male CAD, COPD, CRI, earlier TAA repair
7 88/male CAD, COPD, CRI, thoracic and suprarenal 
aortic aneurysm
CAD, Coronary artery disease; HTN, hypertension; AAA, abdominal aor-
tic aneurysm; COPD, chronic obstructive pulmonary disease; CRI, chronic
renal insufficiency; TAA, thoracoabdominal aneurysm.
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mean of 37 months postoperatively and had no evidence
of infection. Without removal of all aortic prosthetic and
debridement of all infected tissue, eradication of infection
is not likely to occur. However, with broad spectrum
antibiotics and percutaneous drainage, a long-lasting sup-
pression of the infection is possible.
However, all the major complications in this series
were caused by sepsis and occurred in the three patients
with obvious signs of graft infection. The only periopera-
tive death occurred in this group, in a 76-year-old man
with chronic obstructive pulmonary disease and coronary
artery disease who was transferred to our institution with
upper gastrointestinal bleeding, fever, and an elevated
white blood cell count 7 years after elective repair of a tho-
racoabdominal aortic aneurysm. The diagnosis of a tho-
racic AEF was confirmed by means of upper endoscopy. He
was taken to the operating room, and a Talent tube graft
was placed, with immediate cessation of bleeding and
hemodynamic stabilization. Postoperatively, progressive
sepsis developed, and 26 days later he died of overwhelm-
ing Aspergillus fungemia and multiple organ system failure.
Only five patients have been reported to have survived this
uncommon and frequently lethal condition.26 With medi-
astinal esophageal contamination, endovascular repair is an
unlikely means of providing adequate treatment unless
combined with wide drainage and esophageal repair or
diversion. In retrospect, uncontrolled sepsis in this patient
was likely caused by mediastinitis similar to that seen with
primary esophageal perforation. In instances of mediastinal
sepsis, definitive open management should follow initial
endovascular control of hemorrhage.
The other two septic complications were successfully
managed with adjunctive procedures after successful stent-
graft deployment, cessation of bleeding, and hemodynamic
optimization. One patient was treated with CT-guided per-
cutaneous drainage of the infected aneurysm sac. The
other patient had an aortosigmoid fistula and required a
diverting ileostomy performed in the distal ileum to mini-
mize further enteric soilage of the graft. Neither patient
had any further bleeding, and both died at home of causes
unrelated to graft infection or gastrointestinal bleeding
(pneumonia, stroke).
A review of the literature discloses five previously
reported cases of endovascular repair of AEFs. Two of
these patients were reportedly alive and well, without evi-
dence of infection, after 6 and 18 months.24,25 One
patient died after 10 months of myocardial infarction,
without evidence of recurrent infection or bleeding.23
One patient underwent successful axillobifemoral bypass
grafting followed by device removal and aortic ligation
because of recurrent infection with fever and chills 8
Table III. Positive preoperative diagnostic studies
Patient Helical CT Angiography Endoscopy
1 – + –
2 + – + 
3 + – –
4 + – –
5 + + + 
6 + – + 
7 + – –
CT, Computed tomography.
Fig 3. A, Air surrounding a previously placed aortic graft
(arrow). B, Predeployment (left) and postdeployment (right)
intraoperative angiography. A Talent tube graft was placed just
below the renal arteries, excluding the earlier proximal anastomo-
sis that was the site of the aortoenteric fistula. C, Percutaneous
drainage catheter (arrow) placed with CT guidance immediately
after graft deployment.
A
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months after stent-graft placement.21 One patient under-
went successful device removal and aortic homograft
placement 4 weeks after stent-graft placement because of
the discovery of air within the aneurysm sac by means of
CT scanning.22 None of these patients died or sustained
significant morbidity as a result of aortic stent-graft place-
ment. Three of these five patients may need no further
intervention. The two patients in whom endovascular
treatment “failed” had elective surgery under optimal
physiologic conditions rather than emergent surgery in
the setting of hemorrhagic shock, acute renal insufficiency,
and myocardial ischemia.
The results of this study suggest that endovascular aor-
tic stent-graft placement provides a safe and effective
method of rapidly controlling an acutely hemorrhaging
AEF. Without debridement of all contaminated prosthetic
and retroperitoneal tissue, it is not definitive therapy. The
newly placed prosthetic endograft is contaminated by gut
flora. Complete eradication of infection is probably impos-
sible. However, with life-long antibiotic treatment, long-
term suppression of sepsis may be feasible. As seen in this
series, once bleeding is controlled, many patients die of
coexistent cardiopulmonary disease before infection or aor-
tic degeneration becomes a significant problem. Adjunctive
treatments, such as percutaneous drainage and proximal
bowel diversion, may be necessary to contain sepsis in the
setting of gross aortic graft infection. Patients with fistulas
solely to segments of the small bowel were successfully
treated without diversion. However, in the patient with a
colonic fistula, diversion ultimately became necessary. The
patient with an esophageal fistula died of mediastinitis, but
might have benefitted from esophageal diversion had it
been performed. Those patients in whom these measures
fail can still be converted to traditional surgical repair at a
later date, on an elective basis in an optimized physiologic
state. This may translate into an improved outcome for this
unfortunate group. However, no subsequent conversions
have been required in our experience.
CONCLUSION
The treatment of AEFs has improved in recent years.
However, despite the multiple surgical techniques reported,
many of these patients do not survive or are left debilitated
after treatment. Endovascular repair allows for hemodynamic
stabilization, and when combined with broad spectrum
antibiotics and drainage or diversion when necessary, sepsis
may be controlled for prolonged periods. Although not cura-
tive, endovascular repair may provide a bridge to more defin-
itive repair at a later time or provide long-term palliation in
patients who are too sick to undergo major surgery.
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